STRS Ohio’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-61,300
| Closed | -$41K | – | 2081 |
|
|
2024
Q1 | $41K | Hold |
61,300
| – | – | ﹤0.01% | 1783 |
|
|
2023
Q4 | $33K | Hold |
61,300
| – | – | ﹤0.01% | 1817 |
|
|
2023
Q3 | $36K | Hold |
61,300
| – | – | ﹤0.01% | 1832 |
|
|
2023
Q2 | $79K | Hold |
61,300
| – | – | ﹤0.01% | 1756 |
|
|
2023
Q1 | $107K | Hold |
61,300
| – | – | ﹤0.01% | 1706 |
|
|
2022
Q4 | $192K | Hold |
61,300
| – | – | ﹤0.01% | 1599 |
|
|
2022
Q3 | $300K | Hold |
61,300
| – | – | ﹤0.01% | 1488 |
|
|
2022
Q2 | $253K | Buy |
61,300
+3,500
| +6% | +$14.4K | ﹤0.01% | 1535 |
|
|
2022
Q1 | $335K | Hold |
57,800
| – | – | ﹤0.01% | 1566 |
|
|
2021
Q4 | $433K | Hold |
57,800
| – | – | ﹤0.01% | 1525 |
|
|
2021
Q3 | $520K | Buy |
57,800
+17,000
| +42% | +$153K | ﹤0.01% | 1494 |
|
|
2021
Q2 | $488K | Buy |
40,800
+4,700
| +13% | +$56.2K | ﹤0.01% | 1568 |
|
|
2021
Q1 | $452K | Buy |
36,100
+3,400
| +10% | +$42.6K | ﹤0.01% | 1610 |
|
|
2020
Q4 | $510K | Buy |
+32,700
| New | +$510K | ﹤0.01% | 1469 |
|
|
2018
Q4 | – | Sell |
-23,500
| Closed | -$398K | – | 2172 |
|
|
2018
Q3 | $398K | Sell |
23,500
-13,000
| -36% | -$220K | ﹤0.01% | 1487 |
|
|
2018
Q2 | $518K | Buy |
36,500
+3,300
| +10% | +$46.8K | ﹤0.01% | 1355 |
|
|
2018
Q1 | $630K | Buy |
33,200
+3,100
| +10% | +$58.8K | ﹤0.01% | 1216 |
|
|
2017
Q4 | $493K | Hold |
30,100
| – | – | ﹤0.01% | 1328 |
|
|
2017
Q3 | $451K | Buy |
+30,100
| New | +$451K | ﹤0.01% | 1380 |
|
|
2014
Q4 | – | Sell |
-6,100
| Closed | -$66K | – | 1830 |
|
|
2014
Q3 | $66K | Buy |
6,100
+2,200
| +56% | +$23.8K | ﹤0.01% | 1615 |
|
|
2014
Q2 | $60K | Hold |
3,900
| – | – | ﹤0.01% | 1603 |
|
|
2014
Q1 | $71K | Buy |
+3,900
| New | +$71K | ﹤0.01% | 1589 |
|
|
2013
Q4 | – | Sell |
-36,100
| Closed | -$378K | – | 1831 |
|
|
2013
Q3 | $378K | Hold |
36,100
| – | – | ﹤0.01% | 1301 |
|
|
2013
Q2 | $282K | Buy |
+36,100
| New | +$282K | ﹤0.01% | 1422 |
|